Please register (it's free!) or login to view the remaining preview.

If you are logged in, your referral link [?] is automatically included below.

EMBED CODE (Copy and Paste)

DOCUMENT DESCRIPTION

Yielding an mPFS of 6.9 months and MOS of 14.6 months, the Stupp regimen has been the efficacy yardstick and standard treatment protocol followed for newly diagnosed glioblastoma patients. However, this patient segment will witness substantial changes with the introduction of three new immunotherapeutic agents--dendritic-cell vaccines DCVax-L and ICT-107 and PD-1 inhibitor Opdivo-- in the near future

Market growth drivers over the next five years and afterward will be the approval and extension, as well as rapid uptake of, Opdivo in combination with the current standard of care for treatment of all eligible newly diagnosed patients, garnering almost $1 billion total annual sales and a major patient share in all six major pharmaceutical markets we cover by the end of our forecast period. DCVax-L and ICT-107, which are extremely pricey personalized treatments and will face competition from immune checkpoint inhibitors, will experience modest uptake in the first-line setting.

INTRODUCTION
1. Key Findings
2. Market Share of Colorectal Cancer Drug Classes in 2015 and 2025
3. Disease Market SWOT Analysis
ETIOLOGY AND PATHOPHYSIOLOGY
1. Key Findings
2. Expert Insight
3. Disease Overview
4. Disease Pathophysiology
5. Etiology
6. Pathophysiology
KEY PATHWAYS AND DRUG TARGETS
MARKET OUTLOOK
1. Key Findings
2. Expert Insight
3. Market Overview
4. What Factors Are Driving the Market
5. What Factors Are Constraining the Market

Got a question about the product? Email us at [email protected] or ask the author directly by using the form to the right. If you cannot view the preview above this document description, go here to view the large preview instead.

Source: Pharma Disease Insight: Glioma PowerPoint document

Pharma Disease Insight: Glioma

Sold by BigPharma2000 (this author has 41 documents)

$99.00

ALL FEES INCLUDED

Add to Cart

This business document is categorized under the function(s):

Health & Safety Strategy, Marketing, & Sales

It applies to Healthcare & Life Sciences

File Type: PowerPoint (pptx)

File Size: 1.9 MB

Number of Slides: 34 (includes cover, transition slides)

Related Topic(s): Cancer

Purchase includes lifetime product updates. After your purchase, you will receive an email to download this document.

Initial upload date (first version): Jun 8, 2017
Most recent version published: Jun 8, 2017

Ask the Author a Question

Must be logged in Click here to log in

This document is available as part of the following discounted bundle(s):

Pharma Disease Insights: Oncology

$299.00

This bundle contains 4 additional documents.

View Full Details

Pharma Disease Insight: Colorectal Cancer

28-slide PowerPoint deck

$99.00

Author:

Pharma Disease Insight: Gastric Cancer

29-slide PowerPoint deck

$99.00

Author:

Pharma Disease Insights: Multiple Myeloma

29-slide PowerPoint deck

$99.00

Author:

Pharma Disease Insight: Breast Cancer (Oncology)

31-slide PowerPoint deck

$99.00

Author:

CUSTOMER TESTIMONIALS

"Flevy is now a part of my business routine. I visit Flevy at least 3 times each month.

Flevy has become my preferred learning source, because what it provides is practical, current, and useful in this era where the business world is being rewritten.

In today's environment where there are so many challenges and there is the need to make the right decisions in a short time, with so much scattered information, we are fortunate to have Flevy. Flevy investigates, selects, and puts at our disposal the best of the best to help us be successful in our work."

– Omar Hernán Montes Parra, CEO at Quantum SFE

"As a niche strategic consulting firm, Flevy and FlevyPro frameworks and documents are an on-going reference to help us structure our findings and recommendations to our clients as well as improve their clarity, strength, and visual power. For us, it is an invaluable resource to increase our impact and value."

– David Coloma, Consulting Area Manager at Cynertia Consulting

"The wide selection of frameworks is very useful to me as an independent consultant. In fact, it rivals what I had at my disposal at Big 4 Consulting firms in terms of efficacy and organization."

– Julia T., Consulting Firm Owner (Former Manager at Deloitte and Capgemini)

"As a small business owner, the resource material available from FlevyPro has proven to be invaluable. The ability to search for material on demand based our project events and client requirements was great for me and proved very beneficial to my clients. Importantly, being able to easily edit and tailor the material for specific purposes helped us to make presentations, knowledge sharing, and toolkit development, which formed part of the overall program collateral. While FlevyPro contains resource material that any consultancy, project or delivery firm must have, it is an essential part of a small firm or independent consultant's toolbox."

– Michael Duff, Managing Director at Change Strategy (UK)

"If you are looking for great resources to save time with your business presentations, Flevy is truly a value-added resource. Flevy has done all the work for you and we will continue to utilize Flevy as a source to extract up-to-date information and data for our virtual and onsite presentations!"

– Debbi Saffo, President at The NiKhar Group

"Flevy is our 'go to' resource for management material, at an affordable cost. The Flevy library is comprehensive and the content deep, and typically provides a great foundation for us to further develop and tailor our own service offer."

– Chris McCann, Founder at Resilient.World

"One of the great discoveries that I have made for my business is the Flevy library of training materials.

As a Lean Transformation Expert, I am always making presentations to clients on a variety of topics: Training, Transformation, Total Productive Maintenance, Culture, Coaching, Tools, Leadership Behavior, etc. Flevy usually has just what I need to make my point.

It is well worth the money to purchase these presentations. Sure, I have the knowledge and information to make my point. It is another thing to create a presentation that captures what I want to say. Flevy has saved me countless hours of preparation time that is much better spent with implementation that will actually save money for my clients."

– Ed Kemmerling, Senior Lean Transformation Expert at PMG

"As a consulting firm, we had been creating subject matter training materials for our people and found the excellent materials on Flevy, which saved us 100's of hours of re-creating what already exists on the Flevy materials we purchased."

– Michael Evans, Managing Director at Newport LLC

"FlevyPro has been a brilliant resource for me, as an independent growth consultant, to access a vast knowledge bank of presentations to support my work with clients. In terms of RoI, the value I received from the very first presentation I downloaded paid for my subscription many times over! The quality of the decks available allows me to punch way above my weight – it's like having the resources of a Big 4 consultancy at your fingertips at a microscopic fraction of the overhead."

– Roderick Cameron, Founding Partner at SGFE Ltd

"I have found Flevy to be an amazing resource and library of useful presentations for lean sigma, change management and so many other topics. This has reduced the time I need to spend on preparing for my performance consultation. The library is easily accessible and updates are regularly provided. A wealth of great information."

– Cynthia Howard RN, PhD, Executive Coach at Ei Leadership

SELECT CUSTOMERS

Since 2012, we have provided best practices to over 5,000 businesses and organizations of all sizes across the world—in over 130 countries. Below is just a very small sample of our customer base.

Did you know?

The average daily rate of a McKinsey consultant is $6,625 (not including expenses). The average price of a Flevy document is $65.

CUSTOMERS ALSO BOUGHT THESE DOCUMENTS

Market Overview: Multiple Myeloma 27-page PDF document $299.00 Author: pharmzolgas Healthcare Cancer	Pharma Disease Insight: Colorectal Cancer 28-slide PowerPoint deck $99.00 Author: BigPharma2000 Cancer	Pharma Disease Insight: Breast Cancer (Oncology) 31-slide PowerPoint deck $99.00 Author: BigPharma2000 Cancer	Market Overview: Gastric Cancer 27-slide PowerPoint deck $299.00 Author: pharmzolgas Healthcare Cancer
Pharma Disease Insights: Multiple Myeloma 29-slide PowerPoint deck $99.00 Author: BigPharma2000 Cancer	Pharma Disease Insight: Gastric Cancer 29-slide PowerPoint deck $99.00 Author: BigPharma2000 Cancer	Market Overview: Colorectal Cancer 26-page PDF document $299.00 Author: pharmzolgas Healthcare Cancer	Market Overview: Breast Cancer 29-page PDF document $299.00 Author: pharmzolgas Healthcare Cancer
Healthcare Business Capability Model 1-page PDF document $30.00 Author: R Bradley Consulting Healthcare	Pharma Launch Plan 2020 57-slide PowerPoint deck $99.00 Author: BigPharma2000 Healthcare	Lean Healthcare 180-slide PowerPoint deck $79.00 Author: Operational Excellence Consulting Healthcare	Healthcare Go-to-Market Strategy 65-slide PowerPoint deck $49.00 Author: PPT Lab Healthcare